At2g18940 Antibody

What is At2g18940 and what research applications is its antibody suitable for?

At2g18940 refers to a protein-coding gene in Arabidopsis thaliana (Mouse-ear cress), with the antibody being developed specifically for detecting this protein. Based on product specifications, the At2g18940 antibody has been tested for ELISA and Western Blot applications to ensure proper identification of the target antigen . The antibody is derived from immunizing rabbits with recombinant Arabidopsis thaliana At2g18940 protein and is intended strictly for research use only, not for diagnostic or therapeutic applications .

How is the At2g18940 antibody typically validated before experimental use?

Validation of At2g18940 antibody, like other plant antibodies, typically follows a multi-step process. The antibody should be tested via Western blot against both wild-type plant tissues and, ideally, mutant backgrounds lacking the target protein to confirm specificity. Some antibodies in the Arabidopsis collection have been validated this way, including AXR4, ACO2, AtBAP31, and ARF19 . For At2g18940 specifically, validation would include confirming the detection of a protein band of the expected molecular weight in Western blots and possibly immunocytochemistry experiments to verify subcellular localization patterns.

What storage and handling conditions are recommended for maintaining At2g18940 antibody activity?

According to product information, the At2g18940 antibody should be stored at -20°C or -80°C upon receipt, and repeated freeze-thaw cycles should be avoided to maintain activity . The antibody is typically supplied in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . Working dilutions should be prepared fresh before experiments, and the antibody should be handled according to standard laboratory practices for immunological reagents.

How does the method of immunogen production (peptide vs. recombinant protein) affect At2g18940 antibody specificity and performance?

The method of immunogen production significantly impacts antibody performance and specificity. For plant antibodies like At2g18940, research has shown that recombinant protein approaches generally yield better results than peptide-based methods. In a comprehensive study of Arabidopsis antibodies, the success rate with peptide antibodies was very low, whereas recombinant protein-based antibodies showed higher detection rates .

The At2g18940 antibody was developed using a recombinant protein approach, which typically involves bioinformatic analysis to identify potential antigenic regions. The largest antigenic subsequence is then checked for potential cross-reactivity through database searches using blastX, with a cutoff of 40% similarity score at the amino acid level used as a guideline for accepting a given antigenic region . This methodology helps ensure greater specificity for the target protein while minimizing cross-reactivity with related proteins.

What strategies can overcome false positives or non-specific binding when using At2g18940 antibody in complex plant samples?

False positives and non-specific binding are common challenges when working with plant antibodies. Several strategies can mitigate these issues:

• Affinity purification: Research has demonstrated that affinity purification of antibodies massively improves detection rates. In the case of Arabidopsis antibodies, affinity purification significantly enhanced detection specificity .

• Validation in mutant backgrounds: When available, using tissue samples from knockout or knockdown mutants lacking At2g18940 provides the most definitive control for antibody specificity. This approach helps identify non-specific signals that persist in mutant samples .

• Blocking optimization: Experimenting with different blocking agents (BSA, non-fat milk, plant-specific blockers) and concentrations can reduce background and non-specific binding in plant tissues.

• Pre-absorption controls: Pre-incubating the antibody with purified antigen before immunostaining can help identify and eliminate non-specific signals.

• Multiple detection methods: Correlating results from different antibody-based techniques (Western blot, immunoprecipitation, immunohistochemistry) can provide stronger evidence for specific detection.

How can researchers assess potential cross-reactivity of At2g18940 antibody with homologous proteins in non-model plant species?

Assessing cross-reactivity of At2g18940 antibody in non-model plants requires a systematic approach:

• Sequence homology analysis: Researchers should perform sequence alignment of the immunogenic region used to generate the At2g18940 antibody with potential homologs in the target non-model species. The 40% similarity threshold used during antibody development can serve as a reference point - proteins with higher similarity might cross-react .

• Western blot with gradient SDS-PAGE: Running protein extracts from both Arabidopsis and the non-model species side by side can reveal both specific binding and potential cross-reactivity patterns.

• Epitope competition assays: Using synthesized peptides corresponding to the epitope region to compete with endogenous proteins for antibody binding can help determine specificity.

• Immunoprecipitation followed by mass spectrometry: This approach can identify all proteins captured by the antibody in the non-model species, revealing potential cross-reactive proteins.

• Recombinant expression of homologous proteins: Testing the antibody against purified recombinant proteins from the non-model species provides direct evidence of cross-reactivity.

What controls should be included when performing immunolocalization with At2g18940 antibody?

Robust immunolocalization experiments with At2g18940 antibody require several essential controls:

• Negative controls:

  • Omission of primary antibody (secondary antibody only)

  • Preimmune serum at the same concentration as the primary antibody

  • Tissue from knockout/knockdown plants lacking At2g18940 expression

  • Competing peptide block (pre-incubating antibody with excess antigen)

• Positive controls:

  • Tissues known to express At2g18940 at high levels

  • Co-localization with established subcellular markers if the localization is known

  • Parallel detection using fluorescent protein fusions if available

• Technical controls:

  • Titration of antibody concentration to determine optimal signal-to-noise ratio

  • Multiple fixation protocols to ensure epitope accessibility

  • Multiple sections/samples to account for biological variability

How should researchers interpret contradictory results between At2g18940 antibody detection and transcript expression data?

Discrepancies between protein detection using At2g18940 antibody and transcript expression data are not uncommon and can arise from several factors:

• Post-transcriptional regulation: mRNA levels do not always correlate with protein abundance due to differences in translation efficiency, protein stability, and turnover rates.

• Antibody sensitivity limitations: The antibody may have detection thresholds that fail to capture low-abundance proteins, even when transcripts are detected.

• Epitope masking: Protein interactions, post-translational modifications, or conformational changes can mask the epitope recognized by the antibody, leading to false negatives.

• Tissue preparation effects: Different fixation or extraction methods can affect epitope accessibility or protein retention during sample preparation.

When facing contradictory results, researchers should:

• Validate findings using alternative detection methods (e.g., mass spectrometry)

• Examine protein expression using alternative antibodies targeting different epitopes

• Consider using tagged protein constructs to compare with antibody detection

• Investigate potential post-transcriptional or post-translational regulatory mechanisms

• Test for protein stability and turnover rates which may explain differences

What experimental design considerations are crucial when using At2g18940 antibody for protein-protein interaction studies?

When designing protein-protein interaction studies using At2g18940 antibody, researchers should consider:

• Antibody compatibility: Ensure the antibody epitope is not located within or affected by protein-protein interaction domains, which could lead to false negatives due to epitope masking.

• Interaction preservation: Choose extraction and immunoprecipitation conditions (detergents, salt concentration, pH) that maintain relevant protein-protein interactions while enabling efficient antibody binding.

• Cross-linking strategies: Consider whether chemical cross-linking before extraction would better preserve transient or weak interactions.

• Validation approaches: Plan to validate interactions through:

  • Reciprocal co-immunoprecipitation

  • Pull-down with recombinant proteins

  • Proximity ligation assays

  • Split fluorescent protein complementation

  • Yeast two-hybrid or other orthogonal methods

• Controls:

  • Non-specific IgG precipitation controls

  • Competition with excess antigen

  • Analysis of known non-interacting proteins

  • Comparison of interaction in wild-type vs. mutant backgrounds

How can researchers address inconsistent Western blot results when using At2g18940 antibody?

Inconsistent Western blot results with At2g18940 antibody can stem from various sources. Here's a methodical approach to troubleshooting:

• Sample preparation optimization:

  • Test different extraction buffers to ensure complete protein solubilization

  • Add appropriate protease inhibitors to prevent degradation

  • Optimize sample heating conditions (temperature and duration)

  • Ensure consistent protein loading with reliable quantification methods

• Transfer optimization:

  • Test different membrane types (PVDF vs. nitrocellulose)

  • Optimize transfer conditions (voltage, time, buffer composition)

  • Consider using stain-free technology to confirm transfer efficiency

• Antibody conditions:

  • Titrate primary antibody concentration

  • Test different blocking agents (BSA, milk, commercial blockers)

  • Optimize incubation time and temperature

  • Consider using enhanced detection systems for low-abundance proteins

• Reproducibility measures:

  • Standardize protein extraction protocols

  • Include positive controls from validated samples

  • Maintain consistent experimental conditions across replicates

What factors might affect antibody signal variability in immunohistochemistry experiments with plant tissues?

When performing immunohistochemistry with At2g18940 antibody in plant tissues, several factors can contribute to signal variability:

• Tissue fixation and processing:

  • Different fixatives (paraformaldehyde, glutaraldehyde) affect epitope preservation

  • Duration of fixation can impact antibody accessibility

  • Embedding media and sectioning thickness influence antigen detection

• Antigen retrieval methods:

  • Heat-induced epitope retrieval conditions (temperature, pH, duration)

  • Enzymatic digestion parameters for cell wall components

  • Detergent permeabilization variables

• Plant-specific challenges:

  • Cell wall interference with antibody penetration

  • Autofluorescence from phenolic compounds and chlorophyll

  • Endogenous peroxidase activity affecting chromogenic detection

• Antibody incubation parameters:

  • Concentration optimization

  • Incubation time and temperature

  • Washing stringency and duration

• Detection system variations:

  • Secondary antibody selection and optimization

  • Signal amplification methods

  • Substrate development time for enzymatic detection

How can researchers differentiate between specific and non-specific signals when using commercial antibodies like At2g18940?

Distinguishing specific from non-specific signals is a critical challenge, especially considering research showing that some commercial antibodies lack proper validation . Researchers can implement the following strategies:

• Genetic validation:

  • Use knockout or knockdown lines lacking At2g18940 as negative controls

  • Test the antibody in overexpression lines to confirm signal enhancement

  • Employ CRISPR/Cas9-generated mutations affecting the epitope region

• Biochemical validation:

  • Perform peptide competition assays by pre-incubating the antibody with excess antigen

  • Use purified recombinant protein as a positive control

  • Employ size-exclusion techniques to verify the molecular weight of detected signals

• Multiple detection methods:

  • Compare signals across different techniques (Western blot, immunoprecipitation, immunohistochemistry)

  • Correlate antibody detection with alternative approaches (mass spectrometry, activity assays)

  • Use orthogonal methods like fluorescent protein tagging to confirm localization patterns

• Statistical approaches:

  • Quantify signal-to-noise ratios across multiple experiments

  • Perform replicate experiments with blind analysis

  • Use quantitative image analysis to distinguish true signals from background

How might advanced antibody engineering technologies improve the specificity and sensitivity of plant-specific antibodies like At2g18940?

Recent advances in antibody engineering offer promising approaches to enhance plant antibody performance:

• Deep learning approaches for antibody design: Technologies like IgDesign demonstrate the ability to design antibody complementarity-determining regions (CDRs) with high binding success rates . These computational approaches could be adapted to design plant-specific antibodies with improved specificity and affinity.

• High-throughput selection systems: Methods combining mRNA display with microfluidic systems achieve ultrahigh enrichment efficiency (10^6- to 10^8-fold per round), allowing antibodies with high affinity and specificity to be obtained in just one or two selection rounds . These approaches could accelerate the development of plant antibodies.

• Single-chain fragment variables (scFvs): Smaller recombinant antibody fragments might provide better tissue penetration in plant samples, addressing common immunohistochemistry challenges.

• Species-specific framework optimization: Developing plant-optimized antibody frameworks could reduce background binding in plant tissues while maintaining specific antigen recognition.

• Nanobody technology: Single-domain antibodies derived from camelid heavy chain antibodies offer smaller size, higher stability, and potentially better access to certain epitopes that might be inaccessible to conventional antibodies.

What collaborative approaches could address the challenges of antibody validation in plant research communities?

Improving validation standards for plant antibodies like At2g18940 requires coordinated community efforts:

• Centralized validation resources:

  • Expansion of repositories like the Nottingham Arabidopsis Stock Centre that currently houses validated plant antibodies

  • Development of standard validation protocols specific to plant systems

  • Creation of shared knockout/knockdown line collections for negative control testing

• Community-based validation initiatives:

  • Collaborative projects where multiple laboratories test the same antibodies

  • Open platforms for sharing validation data and protocols

  • Peer review of antibody performance across different experimental conditions

• Integration with -omics approaches:

  • Correlation of antibody detection with proteomics data

  • Connection to transcriptomics databases to anticipate expression patterns

  • Integration with structural biology data to better understand epitope accessibility

• Standardized reporting requirements:

  • Detailed documentation of validation methods for published antibodies

  • Minimum information guidelines for antibody characterization

  • Transparent sharing of both positive and negative results